RECK and cancer: The reversion‐inducing cysteine‐rich protein with Kazal motifs (RECK) is considered as a tumour suppressor associated with low invasiveness and favourable prognosis in cancers 27, 28, 29, 30 and suppresses tumour invasive and metastatic potential 31, 32.